Suppr超能文献

微泡联合超声治疗缺血性脑卒中:体内临床前研究的系统评价

Microbubbles combined with ultrasound therapy in ischemic stroke: A systematic review of in-vivo preclinical studies.

作者信息

Auboire Laurent, Sennoga Charles A, Hyvelin Jean-Marc, Ossant Fréderic, Escoffre Jean-Michel, Tranquart François, Bouakaz Ayache

机构信息

UMR Imagerie et Cerveau, Inserm U930, Université François-Rabelais de Tours, France.

CHRU de Tours, Service d'échographie-Doppler, Tours, France.

出版信息

PLoS One. 2018 Feb 8;13(2):e0191788. doi: 10.1371/journal.pone.0191788. eCollection 2018.

Abstract

BACKGROUND

Microbubbles (MBs) combined with ultrasound sonothrombolysis (STL) appears to be an alternative therapeutic strategy for acute ischemic stroke (IS), but clinical results remain controversial.

OBJECTIVE

The aim of this systematic review is to identify the parameters tested; to assess evidence on the safety and efficacy on preclinical data on STL; and to assess the validity and publication bias.

METHODS

Pubmed® and Web of ScienceTM databases were systematically searched from January 1995 to April 2017 in French and English. We included studies evaluating STL on animal stroke model. This systematic review was conducted in accordance with the PRISMA guidelines. Data were extracted following a pre-defined schedule by two of the authors. The CAMARADES criteria were used for quality assessment. A narrative synthesis was conducted.

RESULTS

Sixteen studies met the inclusion criteria. The result showed that ultrasound parameters and types of MBs were heterogeneous among studies. Numerous positive outcomes on efficacy were found, but only four studies demonstrated superiority of STL versus recombinant tissue-type plasminogen activator on clinical criteria. Data available on safety are limited.

LIMITATIONS

Quality assessment of the studies reviewed revealed a number of biases.

CONCLUSION

Further in vivo studies are needed to demonstrate a better efficacy and safety of STL compared to currently approved therapeutic options.

SYSTEMATIC REVIEW REGISTRATION

http://syrf.org.uk/protocols/.

摘要

背景

微泡(MBs)联合超声溶栓(STL)似乎是急性缺血性卒中(IS)的一种替代治疗策略,但临床结果仍存在争议。

目的

本系统评价的目的是确定所测试的参数;评估关于STL临床前数据安全性和有效性的证据;并评估其有效性和发表偏倚。

方法

从1995年1月至2017年4月,对Pubmed®和Web of ScienceTM数据库进行系统检索,检索语言为法语和英语。我们纳入了评估动物卒中模型STL的研究。本系统评价按照PRISMA指南进行。由两位作者按照预先定义的方案提取数据。采用CAMARADES标准进行质量评估。进行了叙述性综合分析。

结果

16项研究符合纳入标准。结果表明,各研究之间超声参数和微泡类型存在异质性。发现了许多关于疗效的阳性结果,但只有4项研究在临床标准上证明了STL优于重组组织型纤溶酶原激活剂。关于安全性的现有数据有限。

局限性

对所审查研究的质量评估揭示了一些偏倚。

结论

需要进一步的体内研究来证明与目前批准的治疗方案相比,STL具有更好的疗效和安全性。

系统评价注册

http://syrf.org.uk/protocols/

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d13/5805249/c0280e59c89a/pone.0191788.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验